Genetic medicines for CF: Hype versus reality

Genetic medicines for CF: Hype versus reality

Since identification of the CFTR gene over 25 years ago, gene therapy for cystic fibrosis (CF) has been actively developed. More recently gene therapy has been joined by other forms of "genetic medicines" including mRNA delivery, as well as genome editing and mRNA repair-based strategies....

書誌詳細
主要な著者:	Alton, E, Boyd, A, Davies, J, Gill, D, Griesenbach, U, Harrison, P, Henig, N, Higgins, T, Hyde, S, Innes, J, Korman, M
フォーマット:	Journal article
言語:	English
出版事項:	Wiley 2016

類似資料

EVALUATION OF SAFETY AND GENE EXPRESSION WITH A SINGLE DOSE OF PGM169/GL67A ADMINISTERED TO THE NOSE AND LUNG OF INDIVIDUALS WITH CF: THE UK CF GENE THERAPY CONSORTIUM "PILOT STUDY"
著者:: Davies, J, 等
出版事項: (2009)

Update on the UK CF Gene Therapy Consortium Multidoes, non-viral, gene therapy trial
著者:: Alton, E, 等
出版事項: (2012)

SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CF
著者:: Davies, J, 等
出版事項: (2011)

UPDATE ON THE UK CF GENE THERAPY CONSORTIUM MULTIDOSE, NON-VIRAL, GENE THERAPY TRIAL
著者:: Alton, E, 等
出版事項: (2012)

UPDATE ON THE UK CF GENE THERAPY CONSORTIUM MULTIDOSE, NON-VIRAL, GENE THERAPY TRIAL
著者:: Alton, E, 等
出版事項: (2012)

A PHASE 2B DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF NON-VIRAL MEDIATED GENE THERAPY FOR CF
著者:: Alton, E, 等
出版事項: (2013)

EVALUATION OF SAFETY AND GENE EXPRESSION WITH A SINGLE DOSE OF PGM169/GL67A ADMINISTERED TO THE NOSE AND LUNG OF INDIVIDUALS WITH CYSTIC FIBROSIS: THE UK CF GENE THERAPY CONSORTIUM "PILOT STUDY''
著者:: Davies, J, 等
出版事項: (2009)

TOXICOLOGY STUDIES IN SUPPORT OF THE UK CF GENE THERAPY CONSORTIUM'S MULTI-DOSE CLINICAL TRIAL
著者:: Griesenbach, U, 等
出版事項: (2011)

Production of SIV-F/HN: a new Lentivirus vector for CF gene therapy
著者:: Hyde, S, 等
出版事項: (2015)

UKCF gene therapy consortium tracking study: Sputum and serum calprotectin are useful novel measurements in CF exacerbation
著者:: Gray, R, 等
出版事項: (2007)

SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CYSTIC FIBROSIS
著者:: Davies, G, 等
出版事項: (2011)

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis
著者:: Alton, E, 等
出版事項: (2013)

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis.
著者:: Alton, E, 等
出版事項: (2013)

EXERCISE CAPACITY AND PHYSICAL ACTIVITY IN PATIENTS WITH CF: DATA FROM THE UK CF GENE THERAPY CONSORTIUM (UKCFGTC) 'RUN-IN' STUDY
著者:: Saunders, C, 等
出版事項: (2010)

LONGITUDINAL ASSESSMENT OF BIOMARKERS FOR CLINICAL TRIALS OF NOVEL THERAPEUTIC AGENTS; THE RUN-IN STUDY
著者:: Alton, E, 等
出版事項: (2010)

From hype to reality: data science enabling personalized medicine
著者:: Holger Fröhlich, 等
出版事項: (2018-08-01)

Three‐Dimensional Bioprinting in Regenerative Medicine: Reality, Hype, and Future
著者:: Anthony Atala, 等
出版事項: (2019-08-01)

DEVELOPMENT, PRODUCTION AND EVALUATION OF CLINICAL GRADE CFTR EXPRESSION PLASMID FOR CF LUNG GENE THERAPY
著者:: Gill, DR, 等
出版事項: (2010)

LONGITUDINAL ASSESSMENT OF BIOMARKERS FOR CLINICAL TRIALS OF NOVEL THERAPEUTIC AGENTS: THE RUN-IN STUDY
著者:: Alton, E, 等
出版事項: (2010)

Platform switching: Hype or reality?
著者:: Shefali Singla, 等
出版事項: (2015-01-01)

E-Learning: The Hype and the Reality
著者:: Gráinne Conole
出版事項: (2004-09-01)

Self-reactive CFTR T cells in humans: implications for gene therapy.
著者:: Calcedo, R, 等
出版事項: (2013)

Pre-existing immunity to human parainfluenza virus (hPIV) does not affect rSIV.F/HN-mediated transduction efficiency
著者:: Pytel, K, 等
出版事項: (2016)

Moving lentiviral-based gene therapy into a first-in-man CF trial
著者:: Griesenbach, D, 等
出版事項: (2015)

Delivery of genes into the CF airway
著者:: Gill, D, 等
出版事項: (2014)

Personalised medicine: the promise, the hype and the pitfalls
著者:: Feiler, T, 等
出版事項: (2017)

The Promise and the hype of 'personalised medicine'
著者:: Maughan, T
出版事項: (2017)

Personalized medicine: hope or hype?
著者:: Salari, K, 等
出版事項: (2012)

Towards a first-in-human trial with a pseudotyped lentivirus
著者:: Alton, EW, 等
出版事項: (2020)

Neurophobia amongst medical students: Hype or reality
著者:: Suzanne Murphy, 等
出版事項: (2024-01-01)

Biotics in pediatrics: Separating hype from reality
著者:: Hania Szajewska
出版事項: (2024-03-01)

Prognostic role of inflammatory markers: Hype or reality?
著者:: Richa Vaish, 等
出版事項: (2020-01-01)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung.
著者:: Alton, E, 等
出版事項: (2014)

Cumulative CFTR expression following repeated aerosol delivery of non-viral pGM169/GL67A formulation to mouse lung
著者:: Alton, E, 等
出版事項: (2012)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung
著者:: Alton, E, 等
出版事項: (2014)

REPEAT ADMINISTRATION OF GL67A/PGM169 IS FEASIBLE, SAFE, AND PRODUCES ENDOGENOUS LEVELS OF CFTR EXPRESSION AFTER 12 DOSES
著者:: Alton, E, 等
出版事項: (2012)

Gene therapy for respiratory diseases; progress and a changing context
著者:: Alton, EWFW, 等
出版事項: (2020)

UK Shale Gas – Hype, Reality and Difficult Questions
著者:: Rogers, H
出版事項: (2013)

Beyond the Hype: Unveiling the Realities of Crypto Trading Journeys
著者:: Muhammad Sohail, 等
出版事項: (2023-12-01)

Bridging between hype and implementation in medical extended reality
著者:: Oscar Freyer, 等
出版事項: (2023-12-01)